Oncolytic poliovirus infects cells expressing the poliovirus receptor (CD155), an oncofetal cell adhesion molecule, which is also expressed in glioblastoma, and subsequently in an immunogenic clearance of cancer cells (Desjardins et al., 2016; Mehta et al., 2017). This evidence concerns the gene PVR and cancer.